|
|
|
42
|
6581S
|
ZOLADEX 3.6MG KIT (AZN) GOSERELIN
|
GOSERELIN
|
ZOLADEX
|
3.6MG KIT
|
BQ
|
205.51
|
205.51
|
KIT
|
0
|
BOX
|
AZN
|
ASTRAZENECA AB
|
COL
|
AVENTA BARBADOS
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
IM
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
6591F
|
DOBUTAMINE 12.5MG/ML INJ (RTM)
|
DOBUTAMINE
|
DOBUTAMINE
|
10X20ML
|
BQ
|
40.77
|
4.08
|
VIAL
|
30
|
VIAL
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
121208
|
BETA ADRENERGIC AGONIST
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
BETA ADRENERGIC AGONIST
|
|
|
|
|
41
|
6591P
|
DOBUTAMINE 12.5MG/ML INJ (SLS) (BQ)
|
DOBUTAMINE
|
DOBUTAMINE
|
20ML
|
BQ
|
9.73
|
9.7316
|
VIAL
|
30
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
121208
|
BETA ADRENERGIC AGONIST
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
BETA ADRENERGIC AGONIST
|
|
|
|
|
40
|
6591R
|
DOBUTAMINE 12.5MG/ML INJ (RTM/PHA)
|
DOBUTAMINE
|
DOBUTAMINE
|
20ML
|
BQ
|
6.03
|
6.03
|
INJECTION
|
0
|
VIAL
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
121208
|
BETA ADRENERGIC AGONIST
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
41
|
6591R
|
DOBUTAMINE 12.5MG/ML INJ (RTM) (BQ)
|
DOBUTAMINE
|
DOBUTAMINE
|
20ML
|
BQ
|
11.47
|
11.4713
|
VIAL
|
30
|
VIAL
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
121208
|
BETA ADRENERGIC AGONIST
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
BETA ADRENERGIC AGONIST
|
|
|
|
|
40
|
6591V
|
LABUTAMINE 12.5MG/ML INJ (LDP/AHI) DOBUTAMINE
|
DOBUTAMINE
|
LABUTAMINE
|
20ML
|
BQ
|
8.07
|
8.07
|
INJECTION
|
0
|
VIAL
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
121208
|
BETA ADRENERGIC AGONIST
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
41
|
66311
|
DIPRIVAN 10MG/ML INJ (ASG) PROPOFOL (C)
|
PROPOFOL
|
DIPRIVAN
|
5X20ML
|
C
|
73.91
|
14.7822
|
AMP
|
30
|
BOX
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
|
2804
|
GENERAL ANESTHETICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
GENERAL ANESTHETICS
|
|
|
|
|
40
|
66318
|
PROPOFOL 10MG/ML INJ (BRA/COL)
|
PROPOFOL
|
PROPOFOL
|
5X20ML
|
BQ
|
13.92
|
2.78
|
INJECTION
|
0
|
VIAL
|
BRA
|
B. BRAUN MELSUNGEN AG CARL-BRAUN-STRABE
|
COL
|
COLLINS LTD
|
|
280492
|
GENERAL ANAESTHETICS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
66318
|
PROPOFOL 10MG/ML INJ (BRA) (BQ)
|
PROPOFOL
|
PROPOFOL
|
5X20ML
|
BQ
|
18.97
|
3.7948
|
VIAL
|
30
|
BOX
|
BRA
|
B. BRAUN MELSUNGEN AG CARL-BRAUN-STRABE
|
COL
|
COLLINS LTD
|
|
280492
|
GENERAL ANAESTHETICS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
GENERAL ANAESTHETICS MISCELLANEOUS
|
|
|
|
|
42
|
66318
|
PROPOFOL 10MG/ML INJ (BRA)
|
PROPOFOL
|
PROPOFOL
|
5X20ML
|
BQ
|
24.46
|
4.89
|
VIAL
|
30
|
VIAL
|
BRA
|
B. BRAUN MELSUNGEN AG CARL-BRAUN-STRABE
|
COL
|
AVENTA BARBADOS
|
|
280492
|
GENERAL ANAESTHETICS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
GENERAL ANAESTHETICS MISCELLANEOUS
|
|
|
|
|
40
|
6631A
|
PROPOFOL 10MG/ML INJ (BRA/COL)
|
PROPOFOL
|
PROPOFOL
|
50ML
|
BQ
|
8.13
|
8.13
|
INJECTION
|
0
|
VIAL
|
BRA
|
B. BRAUN MELSUNGEN AG CARL-BRAUN-STRABE
|
COL
|
COLLINS LTD
|
|
280492
|
GENERAL ANAESTHETICS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
6631A
|
PROPOFOL 10MG/ML INJ (BRA) (BQ)
|
PROPOFOL
|
PROPOFOL
|
50ML
|
BQ
|
8.13
|
8.1278
|
VIAL
|
30
|
VIAL
|
BRA
|
B. BRAUN MELSUNGEN AG CARL-BRAUN-STRABE
|
COL
|
COLLINS LTD
|
|
280492
|
GENERAL ANAESTHETICS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
GENERAL ANAESTHETICS MISCELLANEOUS
|
|
|
|
|
42
|
6631A
|
PROPOFOL 10MG/ML INJ (BRA)
|
PROPOFOL
|
PROPOFOL
|
50ML
|
BQ
|
11.42
|
11.42
|
VIAL
|
30
|
VIAL
|
BRA
|
B. BRAUN MELSUNGEN AG CARL-BRAUN-STRABE
|
COL
|
AVENTA BARBADOS
|
|
280492
|
GENERAL ANAESTHETICS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
GENERAL ANAESTHETICS MISCELLANEOUS
|
|
|
|
|
41
|
6631L
|
PROPOFOL 10MG/ML INJ (KWA) (BQ)
|
PROPOFOL
|
PROPOFOL
|
20ML
|
BQ
|
3.56
|
3.561
|
VIAL
|
30
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
280492
|
GENERAL ANAESTHETICS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
GENERAL ANAESTHETICS MISCELLANEOUS
|
|
|
|
|
40
|
6631Q
|
PROPOFOL 10MG/ML INJ (BAX/STO)
|
PROPOFOL
|
PROPOFOL
|
5X20ML
|
C
|
33.27
|
6.65
|
INJECTION
|
0
|
VIAL
|
BAX
|
BAXTER EXPORT CORP.
|
STO
|
BRYDEN STOKES LTD
|
|
280492
|
GENERAL ANAESTHETICS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
6631R
|
OLEO-LAX 10MG/ML INJ (ABB/PHA) PROPOFOL
|
PROPOFOL
|
OLEO-LAX
|
5X20ML
|
C
|
44.17
|
8.83
|
INJECTION
|
0
|
VIAL
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
280492
|
GENERAL ANAESTHETICS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
6631R
|
OLEO-LAX 10MG/ML (ABB/PHA) PROPOFOL (C)
|
PROPOFOL
|
OLEO-LAX
|
5X20ML
|
C
|
44.17
|
8.834
|
INJECTION
|
|
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
280492
|
GENERAL ANAESTHETICS MISCELLANEOUS
|
2022-04-01
|
2023-03-31
|
Delete from contract
|
IV
|
0
|
GENERAL ANAESTHETICS MISCELLANEOUS
|
2023-03-07
|
|
|
|
42
|
6631Y
|
PROPIFOL 10MG/ML INJ (JLP) PROPOFOL
|
PROPOFOL
|
PROPIFOL
|
20X20ML
|
BQ
|
35.88
|
1.79
|
VIAL
|
0
|
VIAL
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
280492
|
GENERAL ANAESTHETICS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
GENERAL ANAESTHETICS MISCELLANEOUS
|
|
|
|
|
40
|
66511
|
INALIX SR 1.5MG TAB (HEA/RXP) INDAPAMIDE
|
INDAPAMIDE
|
INALIX SR
|
3X10
|
C
|
2.91
|
0.10
|
TABLET
|
0
|
TAB
|
HEA
|
HEALTH 2000 INC
|
RXP
|
RX PRO INC
|
B
|
402824
|
THIAZIDE LIKE DIURETICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ELECTROLYTIC, CALORIC, AND WATER BALANCE
|
|
|
|
|
40
|
6651A
|
NATRILIX SR 1.5MG TAB (SER/STO) INDAPAMIDE
|
INDAPAMIDE
|
NATRILIX SR
|
30'S
|
A
|
5.98
|
0.20
|
TABLET
|
30
|
TAB
|
SER
|
LES LABORATOIRES SERVIER
|
STO
|
BRYDEN STOKES LTD
|
B
|
402824
|
THIAZIDE LIKE DIURETICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ELECTROLYTIC, CALORIC, AND WATER BALANCE
|
|
